Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens

被引:26
|
作者
Bousquet, E
Morvan, H
Aitken, I
Morgan, JH
机构
[1] LAB DEV & ANAL,F-22440 PLOUFRAGAN,FRANCE
[2] INST ANIM HLTH,NEWBURY RG20 7NN,BERKS,ENGLAND
关键词
D O I
10.1136/vr.141.2.37
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Minimum inhibitory concentrations of doxycycline and oxytetracycline were determined against 55 Pasteurella multocida strains, 59 Actinobacillus pleuropneumoniae strains and 26 Mycoplasma hyopneumoniae strains isolated from the respiratory tract of pigs, An additional set of 76 P multocida strains isolated from pneumonic pigs was tested for their minimum inhibitory concentrations of doxycycline, The P multocida and A pleuropneumoniae strains were isolated in France and the minimum inhibitory concentrations were determined by an agar dilution method, The M hyopneumoniae strains were isolated in the United Kingdom and minimum inhibitory concentrations were determined by a serial broth dilution method, All the strains tested were susceptible to doxycycline whereas 15 per cent of the P multocida strains and 22 per cent of the A pleuropneumoniae strains were resistant to oxytetracycline. Doxycycline concentrations inhibiting 90 per cent of strains were 1 mu g/ml for P multocida and 2 mu g/ml for A pleuropneumoniae. The ratio of the minimum inhibitory concentrations of doxycycline and oxytetracycline ranged between 1/1 and 1/4 for the oxytetracycline-susceptible strains and between 1/16 and 1/64 for the oxytetracycline-resistant strains. All the M hyopneumoniae strains were susceptible to doxycycline and oxytetracycline, the concentrations inhibiting 90 per cent of strains being 1 mu g/ml and 2 mu g/ml, respectively. These data confirm that doxycycline has a higher in vitro activity against pig respiratory pathogens than oxytetracycline.
引用
收藏
页码:37 / 40
页数:6
相关论文
共 50 条
  • [1] ACTIVITY OF DOXYCYCLINE AGAINST RESPIRATORY PATHOGENS
    BUTZLER, JP
    CHEMOTHERAPY, 1975, 21 : 116 - 120
  • [2] Comparative in vitro activity of valnemulin against porcine bacterial pathogens
    Aitken, IA
    Morgan, JH
    Dalziel, R
    Burch, DGS
    Ripley, PH
    VETERINARY RECORD, 1999, 144 (05) : 128 - 128
  • [3] Antibacterial activity against porcine respiratory bacterial pathogens and in vitro biocompatibility of essential oils
    Geneviève LeBel
    Katy Vaillancourt
    Philippe Bercier
    Daniel Grenier
    Archives of Microbiology, 2019, 201 : 833 - 840
  • [4] Antibacterial activity against porcine respiratory bacterial pathogens and in vitro biocompatibility of essential oils
    LeBel, Genevieve
    Vaillancourt, Katy
    Bercier, Philippe
    Grenier, Daniel
    ARCHIVES OF MICROBIOLOGY, 2019, 201 (06) : 833 - 840
  • [5] Comparative in vitro activity of cider and newer fluoroquinolones against respiratory tract pathogens
    Esposito, S
    Noviello, S
    Ianniello, F
    CHEMOTHERAPY, 2000, 46 (05) : 309 - 314
  • [6] In vitro activity of faropenem against respiratory pathogens
    du Plessis, MN
    Capper, TP
    Klugman, KP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 575 - 577
  • [7] In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens
    Priebe, S
    Schwarz, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) : 2703 - 2705
  • [8] In-vitro susceptibility of porcine respiratory tract pathogens against florfenicol
    Schwarz, S
    Kehrenberg, C
    Mumme, J
    Wallmann, J
    Verspohl, J
    Tegeler, R
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 223 - 223
  • [9] In vitro activity of fluoroquinolones against common respiratory pathogens
    Aydemir, S.
    Tunger, A.
    Cilli, F.
    WEST INDIAN MEDICAL JOURNAL, 2006, 55 (01): : 9 - 12
  • [10] In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens
    Harding, Sarah V.
    Barnes, Kay B.
    Hawser, Stephen
    Bentley, Christine E.
    Vente, Andreas
    ANTIBIOTICS-BASEL, 2023, 12 (07):